Author
Chroma Ventures
Date
August 4, 2022
Category
The commitment was made as part of a successful £250m fundraise which will enable OSE to further support its existing portfolio and create new spinout companies across life sciences, health technology and deep technology.
Commenting on the investment, our principal Chris van der Kuyl said,
Chroma Ventures is delighted to support OSE with this investment and we also look forward to supporting investee companies directly where our interests cross over.
Read more about OSE and the £250m fundraise here.